XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Investments:    
Fixed maturity securities, available for sale, at fair value (amortized cost of $43,323,015 as of 2023 and $44,866,019 as of 2022; allowance for credit losses of $4,146 as of 2023 and $3,347 as of 2022) $ 38,680,457 $ 39,804,617 [1]
Mortgage loans, carrying value 7,373,609 6,949,027 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,069,965 and $684,834 related to consolidated variable interest entities) 1,649,959 1,266,779 [1]
Derivative instruments 1,131,597 431,727 [1]
Other investments 1,412,939 1,817,085 [1]
Total investments 51,518,774 51,325,298 [1]
Cash and cash equivalents (2023 and 2022 include $44,919 and $27,235 related to consolidated variable interest entities) 5,000,657 1,919,669 [1]
Coinsurance deposits (net of allowance for credit losses of $3,392 as of 2023 and $8,737 as of 2022) 14,247,284 13,254,956 [1]
Market risk benefits 234,470 229,871 [1]
Accrued investment income (2023 and 2022 include $3,745 and $3,444 related to consolidated variable interest entities) 488,396 497,851 [1]
Deferred policy acquisition costs 2,842,615 2,773,643 [1]
Deferred sales inducements 2,134,254 2,045,683 [1]
Deferred income taxes 293,466 438,434 [1]
Income taxes recoverable 55,678 55,498 [1]
Other assets (2023 and 2022 include $19,726 and $10,690 related to consolidated variable interest entities) 829,831 642,696 [1]
Total assets 77,645,425 73,183,599 [1]
Liabilities:    
Policy benefit reserves 59,856,677 58,781,836 [1]
Market risk benefits 2,673,272 2,455,492 [1]
Other policy funds and contract claims 202,251 512,790 [1]
Notes and loan payable 788,754 792,073 [1]
Subordinated debentures 78,927 78,753 [1]
Funds withheld for reinsurance liabilities 7,565,295 6,577,426 [1]
Other liabilities (2023 and 2022 include $94,705 and $78,644 related to consolidated variable interest entities) 3,885,208 1,614,479 [1]
Total liabilities 75,050,384 70,812,849 [1]
Stockholders' equity:    
Common stock; par value $1 per share; 200,000,000 shares authorized; issued and outstanding: 2023 - 78,047,941 shares (excluding 31,713,969 treasury shares); 2022 - 84,810,255 shares (excluding 24,590,353 treasury shares) 78,048 84,810 [1]
Additional paid-in capital 1,055,963 1,325,316 [1]
Accumulated other comprehensive loss (3,425,248) (3,746,230) [1]
Retained earnings 4,863,124 4,685,593 [1]
Total stockholders' equity attributable to American Equity Investment Life Holding Company 2,571,915 2,349,517 [1]
Noncontrolling interests 23,126 21,233 [1]
Total stockholders' equity 2,595,041 2,370,750 [1]
Total liabilities and stockholders' equity 77,645,425 73,183,599 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A    
Stockholders' equity:    
Preferred stock 16 16 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B    
Stockholders' equity:    
Preferred stock 12 12 [1]
Variable Interest Entities    
Investments:    
Real estate investments related to consolidated variable interest entities 1,270,213 1,056,063 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,069,965 and $684,834 related to consolidated variable interest entities) 1,069,965 684,834
Cash and cash equivalents (2023 and 2022 include $44,919 and $27,235 related to consolidated variable interest entities) 44,919 27,235
Accrued investment income (2023 and 2022 include $3,745 and $3,444 related to consolidated variable interest entities) 3,745 3,444
Other assets (2023 and 2022 include $19,726 and $10,690 related to consolidated variable interest entities) 19,726 10,690
Total assets 2,408,568 1,782,266
Liabilities:    
Other liabilities (2023 and 2022 include $94,705 and $78,644 related to consolidated variable interest entities) 94,705 78,644
Total liabilities $ 94,705 $ 78,644
[1] Certain prior period amounts have been recast. See Note 1 - Significant Accounting Policies for more information.